Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China
· Delayed Price · Currency is CNY 13.96
-0.19 (-1.34%)
Apr 29, 2026, 3:00 PM CST
SHA:603456 Revenue
Zhejiang Jiuzhou Pharmaceutical had revenue of 1.20B CNY in the quarter ending March 31, 2026, a decrease of -19.43%. This brings the company's revenue in the last twelve months to 5.22B, up 0.85% year-over-year. In the year 2025, Zhejiang Jiuzhou Pharmaceutical had annual revenue of 5.51B with 6.74% growth.
Revenue (ttm)
5.22B
Revenue Growth
+0.85%
P/S Ratio
2.39
Revenue / Employee
1.04M
Employees
5,001
Market Cap
12.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.51B | 348.01M | 6.74% |
| Dec 31, 2024 | 5.16B | -362.83M | -6.57% |
| Dec 31, 2023 | 5.52B | 78.31M | 1.44% |
| Dec 31, 2022 | 5.45B | 1.38B | 34.01% |
| Dec 31, 2021 | 4.06B | 1.42B | 53.48% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.98B |
| Shenzhen Chipscreen Biosciences | 910.06M |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Guobang Pharma | 6.09B |
| Zhejiang Hisun Pharmaceutical | 10.31B |
| Zhejiang Medicine | 8.82B |
| Ningbo Menovo Pharmaceutical | 1.56B |
| Guangdong Taienkang Pharmaceutical | 674.49M |